A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women
Status: | Archived |
---|---|
Conditions: | Osteoporosis, Postmenopausal Syndrome |
Therapuetic Areas: | Endocrinology, Rheumatology |
Healthy: | No |
Age Range: | Any |
Updated: | 7/1/2011 |
Start Date: | November 2010 |
End Date: | March 2011 |
This study is a Phase 1, multi-center, 2-part, subject- and investigator-blind, randomized,
placebo-controlled, multiple dose study of transdermal teriparatide (80-µg dose) in healthy
postmenopausal women. Part A will examine the cumulative irritation and adherence of the
transdermal patch, and Part B will examine skin sensitization and adherence. Two separate
groups of subjects will be enrolled for Part A and Part B of the study. All screening
procedures will take place up to 28 days prior to enrollment.
We found this trial at
2
sites
1 Medical Center Drive
Morgantown, West Virginia 26506
Morgantown, West Virginia 26506
304-598-4800
West Virginia University Hospitals Inc. WVU Healthcare is two corporations, University Health Associates and WVU...
Click here to add this to my saved trials
Click here to add this to my saved trials